Globeflex Capital’s Astrana Health ASTH Stock Holding History

Globeflex Capital’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24	Closed	-$758	–	508
2023 Q2	$758	Buy	+24	New	+$823	﹤0.01%	464

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Globeflex Capital's ASTH Position: Q3 2023 in Review

Globeflex Capital sold out of Astrana Health (ASTH) in Q3 2023, closing a stake of 24 shares — an estimated $758 sold.

Globeflex Capital first reported a position in ASTH in Q2 2023 and held it in 1 quarter. The position peaked at $758 in Q2 2023. 134 funds tracked by Wall St. Rank hold ASTH as of Q3 2023.

Globeflex Capital reported no remaining Astrana Health position as of Q3 2023 after selling out during the quarter.
Globeflex Capital sold 24 Astrana Health shares in Q3 2023, an estimated $758.
Globeflex Capital first reported a position in Astrana Health in Q2 2023 and held it in 1 quarter.
Globeflex Capital's Astrana Health position peaked at $758 in Q2 2023.
134 funds tracked by Wall St. Rank held Astrana Health as of Q3 2023.

Based on Globeflex Capital's 13F filing for Q3 2023, filed 13 Nov 2023.